WhiteBoard style discussion on a new therapy that the FDA has approved for studies called Aviptadil or RLF-100. This is a synthetic Vasoactive Intestinal Peptide (VIP). We will discuss its mechanism of action, preceding evidence to support its possible efficacy,…

Live discussion topics: Aviptadil (RLF-100), Synairgen (SNG001), Interferon-beta, COVID-19 vaccine, COVID-19 Paper Test